MENU

JDRF advocates gather to say thanks
Published on October 4, 2017
Research Progress

More than 80 advocates join supporters and the Prime Minister to celebrate a decade of Australian government investment in type 1 diabetes research. On a glorious Sydney day, JDRF supporters and advocates were hosted by the Prime Minister, Malcolm Turnbull at Kirribilli House to mark ten years of federal government support for type one research.

Share
Islet transplantation in Australia: A journey from bench to bedside
Published on September 27, 2017

A decade ago, islet transplantation was just an experimental procedure confined to labs across Australia. Today, thanks to Government support driven by JDRF advocates, islet transplantation has been a reality for a group of eligible adults with type 1 diabetes (T1D), and there are intensive research efforts behind making the procedure even wider-reaching.

Share
Future Research Leaders: Dr Eliana Marino talks to JDRF
Published on July 14, 2017

Dr Eliana Marino is one of our first seven participants in the pilot year of the JDRF/Macquarie Group Foundation Future Research Leaders Program (FRLP). Hailing from Venezuela, the bubbly Dr Marino speaks with exuberance and energy. She sees beyond what’s happening on the laboratory benchtop, to how the type 1 diabetes community will benefit as […]

Share

At the world’s largest diabetes research conference, held last month, JDRF-funded researchers highlighted exciting breakthroughs and vital work that is paving the way to new type 1 diabetes therapies. More than 18,000 physicians, researchers, health care professionals and patient advocates attended the event, which highlights the latest findings in all major areas of the diabetes research […]

Share

An American research team, partly funded by JDRF, have developed a hydrogel material that increased islet survival and function after transplantation in mice. The research, published in Science Advances, used a degradable hydrogel material combined with a protein called vascular endothelial growth factor (VEGF), to stimulate the growth of blood vessels into transplanted cells.

Share

 Two promising research projects have been targeted to receive contract seed funding grants, and will benefit from $350k in funding from the Type 1 Diabetes Clinical Research Network (T1DCRN), itself an innovative clinical research program led by JDRF Australia and funded by a Special Research Initiative through the Australian Research Council (ARC). These two projects […]

Share

A new technique that uses modified insulin and red blood cells to create a glucose-responsive insulin (GRI) delivery system has been developed by researchers from North Carolina State University and the University of North Carolina in the USA. The new technique effectively reduced blood sugar levels for more than 48 hours in mice that had type 1 diabetes. […]

Share

About one third of individuals with type 1 diabetes will develop kidney complications during their lifetime. Current treatment options for diabetic kidney disease can slow but not stop its progression, highlighting an urgent need for new approaches. Scientists at Boston’s Joslin Diabetes Center have revealed an unexpected route to slow the progression of diabetic kidney […]

Share